Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel

Among patients with hormone receptor (HR)-positive breast cancer, those with residual disease after neoadjuvant chemotherapy have a higher risk of relapse and poorer survival than those with a complete response. Previous studies have revealed a correlation between activation of cell cycle-regulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Trapé, Adriana Priscila, Liu, Shuying, Cortes, Andrea Carolina, Ueno, Naoto T., Gonzalez-Angulo, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910587/
https://www.ncbi.nlm.nih.gov/pubmed/27313785
http://dx.doi.org/10.7150/jca.14441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910587/
https://www.ncbi.nlm.nih.gov/pubmed/27313785
http://dx.doi.org/10.7150/jca.14441

Ejemplares similares